[PAR] QoQ Quarter Result on 30-Jun-2020 [#Q4]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
29-Jun-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q4]
Profit Trend
QoQ- -40.97%
YoY- 35.91%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 CAGR
Revenue 45 21 0 -826 826 2,956 28 17.11%
PBT -26,985 -13,567 -20,730 -7,195 -5,104 -11,227 -4,400 82.94%
Tax 0 0 -0 -826 826 2,956 0 -
NP -26,985 -13,567 -20,730 -7,195 -5,104 -11,227 -4,400 82.94%
Tax Rate - - - - - - - -
Total Cost 27,030 13,587 20,730 6,369 5,930 14,183 4,428 82.65%
Ratio Analysis
31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 CAGR
NP Margin -59,701.41 -66,017.95 0.00 871.10 -617.95 -379.84 -15,637.06 56.23%
Per Share
31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 CAGR
EPS -0.11 -0.06 -0.09 -0.03 -0.03 -0.08 -0.03 54.14%
EPS Diluted -0.11 -0.06 -0.09 -0.03 -0.03 -0.08 -0.03 54.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.